TMHC (Taylor Morrison Home Corporation Common Stock) Stock Analysis - Insider Trades
Taylor Morrison Home Corporation Common Stock (TMHC) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, TMHC trades at $57.69 with a market cap of $5.23B and a P/E ratio of 7.26. TMHC moved +0.00% today. Year to date, TMHC is -2.51%; over the trailing twelve months it is -2.26%. Its 52-week range spans $51.90 to $75.49. Analyst consensus is buy with an average price target of $64.50. Rallies surfaces TMHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading TMHC stock inside the company?
Recent TMHC insider activity includes Warren Denise sold 2.98K, Warren Denise sold 100, Merrill Stevin Todd sold 4.41K, MARIUCCI ANNE L sold 14.00K, and Palmer Sheryl sold 13.51K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
TMHC Key Metrics
Key financial metrics for TMHC
Metric
Value
Price
$57.69
Market Cap
$5.23B
P/E Ratio
7.26
EPS
$7.90
Dividend Yield
0.00%
52-Week High
$75.49
52-Week Low
$51.90
Volume
6.77K
Avg Volume
0
Revenue (TTM)
$8.12B
Net Income
$791.26M
Gross Margin
23.03%
Recent TMHC Insider Trades
Warren Denise sold 2.98K (~$205.87K) on Feb 13, 2026.
Warren Denise sold 100 (~$6.93K) on Feb 13, 2026.
Merrill Stevin Todd sold 4.41K (~$309.02K) on Sep 12, 2025.
MARIUCCI ANNE L sold 14.00K (~$980.14K) on Sep 11, 2025.
Palmer Sheryl sold 13.51K (~$973.75K) on Sep 5, 2025.
Recent TMHC insider activity includes Warren Denise sold 2.98K, Warren Denise sold 100, Merrill Stevin Todd sold 4.41K, MARIUCCI ANNE L sold 14.00K, and Palmer Sheryl sold 13.51K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TMHC?
Yes. Rallies tracks TMHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TMHC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TMHC. It does not provide personalized investment advice.